Affymax (AFFY) Shows Signs of Life
Tweet
Share
E-mailGet Alerts AFFY Hot Sheet
Join SI Premium – FREE
Affymax (Nasdaq: AFFY) showed signs of life on Tuesday, gaining 37%. Investors in the stock were punished earlier this year after the company recalled OMONTYS injections due to reports of serious hypersensitivity reactions. Since then share are lower by about 95%.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PBOC To Boost Credit Support For China's Property Sector
- SpaceX's Musk: My best guess for ~$3.5T revenue is roughly around 2033
- White House Spurns A Return To June Deal With Iran - WSJ
Create E-mail Alert Related Categories
Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
